RETNLB and metabolic dysfunction-associated steatohepatitis: Furthermore, RELMβ knockout mice were resistant to a methionine- and choline-deficient (MCD) diet, suggesting the contribution of increases in RELMβ to NASH development and raising the possibility that RELMβ is a novel therapeutic target for this pathology (60).